These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23489201)

  • 1. Innovative formulations for the controlled and site-specific delivery of antiinflammatory drugs.
    Serpe L; Canaparo R; Foglietta F; Zara GP
    Curr Pharm Des; 2013; 19(41):7219-36. PubMed ID: 23489201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel controlled local drug delivery system for inner ear disease.
    Paulson DP; Abuzeid W; Jiang H; Oe T; O'Malley BW; Li D
    Laryngoscope; 2008 Apr; 118(4):706-11. PubMed ID: 18182968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modified release intra-articular drug delivery systems].
    Szabó A; Szabó B; Balogh E; Zelkó R; Antal I
    Acta Pharm Hung; 2012; 82(2):69-74. PubMed ID: 22870779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel drug delivery systems for sustained and targeted delivery of anti- cancer drugs: current status and future prospects.
    Utreja P; Jain S; Tiwary AK
    Curr Drug Deliv; 2010 Apr; 7(2):152-61. PubMed ID: 20158482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical technology can turn a traditional drug, dexamethasone into a first-line ocular medicine. A global perspective and future trends.
    Rodríguez Villanueva J; Rodríguez Villanueva L; Guzmán Navarro M
    Int J Pharm; 2017 Jan; 516(1-2):342-351. PubMed ID: 27889587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel oral drug formulations. Their potential in modulating adverse effects.
    Florence AT; Jani PU
    Drug Saf; 1994 Mar; 10(3):233-66. PubMed ID: 8043223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles.
    Boisgard AS; Lamrayah M; Dzikowski M; Salmon D; Kirilov P; Primard C; Pirot F; Fromy B; Verrier B
    Eur J Pharm Biopharm; 2017 Jul; 116():51-60. PubMed ID: 27702687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging role of colloidal drug delivery systems (CDDS) in NSAID topical administration.
    Puglia C; Tirendi GG; Bonina F
    Curr Med Chem; 2013; 20(14):1847-57. PubMed ID: 23410154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimising the controlled release of dexamethasone from a new generation of PLGA-based microspheres intended for intravitreal administration.
    Rodríguez Villanueva J; Bravo-Osuna I; Herrero-Vanrell R; Molina Martínez IT; Guzmán Navarro M
    Eur J Pharm Sci; 2016 Sep; 92():287-97. PubMed ID: 26987610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will non-steroid approaches to the treatment of inflammation replace our need for glucocorticoids?
    Whelan CJ
    Curr Opin Investig Drugs; 2003 May; 4(5):536-43. PubMed ID: 12833646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery system for budesonide based on lipid-DNA.
    Liu Y; Bos IST; Oenema TA; Meurs H; Maarsingh H; Hirsch AKH
    Eur J Pharm Biopharm; 2018 Sep; 130():123-127. PubMed ID: 29908939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in drug delivery systems for treating ocular complications of systemic diseases.
    Lee SS; Hughes PM; Robinson MR
    Curr Opin Ophthalmol; 2009 Nov; 20(6):511-9. PubMed ID: 19667987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Old Drugs, New Tricks" - Local controlled drug release systems for treatment of degenerative joint disease.
    Tryfonidou MA; de Vries G; Hennink WE; Creemers LB
    Adv Drug Deliv Rev; 2020; 160():170-185. PubMed ID: 33122086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulizer-compatible liquid formulations for aerosol pulmonary delivery of hydrophobic drugs: glucocorticoids and cyclosporine.
    Klyashchitsky BA; Owen AJ
    J Drug Target; 1999; 7(2):79-99. PubMed ID: 10617295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric delivery systems for dexamethasone.
    Urbańska J; Karewicz A; Nowakowska M
    Life Sci; 2014 Feb; 96(1-2):1-6. PubMed ID: 24373835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel delivery systems for anti-allergic agents: allergic disease and innovative treatments.
    Lopes CM; Coelho PB; Oliveira R
    Curr Drug Deliv; 2015; 12(4):382-96. PubMed ID: 25895551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary delivery of anti-inflammatory agents.
    Ali ME; McConville JT; Lamprecht A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):929-45. PubMed ID: 25534260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.
    Suresh PK; Sah AK
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1747-68. PubMed ID: 25007007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.